JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Radiology Section DOI : 10.7860/JCDR/2016/24387.8885
Year : 2016 | Month : Nov | Volume : 10 | Issue : 11 Full Version Page : TC18 - TC23

Role of HRCT Chest in Post Stem Cell Transplant Recipients Suspected of Pulmonary Complications

Abhishek Dwivedi1, R Ravi Kumar2, Ajay Sharma3, S K Pannu4

1 Graded Specialist, Radiology, Department of Radiodiagnosis, Army Hospital (Research and Referral), New Delhi, India.
2 Professor and Head of Department, Department of Diagnostic and Interventional Radiology, Armed Forces Medical College, Pune, Maharashtra India.
3 Professor and Head of Department, Department of Haematology and Stem Cell Transplant, Army Hospital (Research and Referral), New Delhi, India.
4 Graded Specialist Radiology, Department of Radiodiagnosis, Army Hospital (Research and Referral), New Delhi, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Abhishek Dwivedi, Department of Radiodiagnosis, Army Hospital Research and Referral, Dhaula Kuan, Delhi Cantt-110010, Delhi, India.
E-mail: abhishek232464@yahoo.com
Abstract

Introduction

Stem cell transplantation is today’s procedure of choice for management of various hematopoietic malignant and severe immunogenic disorders. High Resolution Computed Tomography (HRCT) is a common technique for the diagnosis of pulmonary complications in stem cell transplant recipients. There are a large number of complications which can complicate the post-transplant period.

Aim

To study the role of HRCT chest in stem cell transplant patients developing pulmonary complications, detect any evidence of infection, detect clinical signs of lung infections, Graft versus Host Disease (GvHD) or other regimen related toxicities outlined earlier, detect any evidence of GvHD and correlate these clinical signs with radiological changes in the lungs.

Materials and Methods

The study was a prospective study of 52 participants with indication of stem cell transplantation. The study included recipients of HSCT transplant and the exclusion criteria was patients who failed for engraftment and having an associated history of pulmonary embolism. Patients were screened for pre-transplant chemotherapy, clinical examination, laboratory investigations including blood and biochemical examinations, imaging by ultrasound, chest radiography, baseline HRCT and a follow-up for post-transplant infections and complications with 16 slice Siemens CT scan. Statistical analysis was done using Pearson’s chi-squared test.

Results

Four patients among the total 56 were excluded due to non-engraftment. The most common associated findings in decreasing order are (these patients died): consolidation, pancytopenia and gastrointestinal tract symptoms with VOD (Veno-Occlusive Disease). These findings were seen on HRCT as consolidation, cavities, ground glass opacities, fibrotic changes, bronchiectatic changes and tree in bud appearance.

Conclusion

The study highlights the significant positive findings on the HRCT which were missed on routine chest radiograph and can be used for early diagnoses. Thus, HRCT helped in decreasing the mortality. The abnormal vitals and TLC counts showed a significant relation between the numbers of death in the study.

Keywords

Introduction

Hematopoietic Stem Cell Transplantation (HSCT) is an emerging management modality of various haematopoietic malignant and severe immunologic disorders, haematological disorders [1]. India has come a long way in the field of HSCT. Indications of HSCT are malignant, non-malignant, storage and metabolic disorders. HSCT recipients have been limited to, studies including only small number of patients and such studies are rare in India as this facility is limited to very few hospitals [2].

The main component of bone marrow, which ensures hematopoietic regeneration, is the pluripotent stem cell - which has been characterized by immune-phenotyping. Depending upon the donor, the transplantation is called allogeneic, autologous or from an identical twin called syngenic [3].

For the procedure, the recipient and donors undergoes matching for the blood group, HLA, complete blood counts and microbiological examinations, to rule out any active infection. Complete biochemical investigations for ruling out any organ dysfunction is also done. After matching, recipient requires immunosuppression to reduce Graft versus Host Disease (GvHD). Mobilization consists of the use of growth factors or chemotherapy agents for collecting enough stem cells from donor which can be from the marrow, peripheral blood, umbilical cord and amniotic fluid. These harvested stem cells are then cryopreserved and then infused after thawing. In vitro manipulation is done primarily to reduce the relapse and GvHD. This is done by either treating the marrow cells by monoclonal antibodies reactive to T cells or leukaemia cells using complement or incubated with drugs as mafosfamide [35].

The conditioning is primarily aimed for eradication of the recipient clone (normal and malignant cells), to create space for the recipient stem cells and to cause immunosuppression [6].

Pulmonary complications of HSCT: Amongst all the complications of the HSCT the pulmonary complications account for significant morbidity and mortality. These complications can be in the form of infections, GvHD and regimen related toxicities like interstitial pneumonitis, bronchiolitis obliterans, diffuse alveolar haemorrhage etc., [7,8].

Radiological description of the pulmonary complications reflects the immunogenic status of the patients and occurs in three periods [711]:

1) The neutropenic period (up to 3 weeks after the transplant) is characterized by fungal infections, notably angioinvasive aspergillosis, alveolar haemorrhage, pulmonary oedema and drug reactions;

2) The mid period (3 week to 100 days) primarily shows CMV pneumonia;

3) Late period (>100 days post-transplant) is characterized by Bronchiolitis Obliterans (BO), Bronchiolitis Obliterans with Organizing Pneumonia (BOOP) and Chronic GvHD.

HRCT(High Resolution Computed Tomography): This is a non-contrast CT acquisition and reconstruction method which produces highly detailed images of very high resolution due to acquisition of thin slices of 0.5 to 1mm with high frequency reconstruction algorithms [10].

Today, continuous spiral acquisition technique is used which has replaced the older ‘incremental’ acquisition technique where 1-mm slices were acquired with an image interval of 10 mm [12].

This study primarily focuses on the radiological features of the pulmonary complication HSCT, its use for early diagnosis and treatment to reduce mortality and morbidity in the recipients.

Materials and Methods

This was a prospective observational study, conducted after clearance from the Ethical Committee, from October 2013 to March 2015. It included 52 patients who had undergone HSCT during this period in the hospital. All patients underwent complete clinical examination and laboratory investigations as Complete Blood Count (CBC), serum biochemistry, USG abdomen, chest radiography, baseline HRCT on Philips Brilliance multiphasic 16 slice HRCT chest, post transplant HRCT when suspected clinical abnormalities and either BAL (Broncho-Alveolar Lavage) and sputum examination. Patients who did not achieve engraftment and patients with evidence of pulmonary embolism were excluded from the study.

The patients were observed during the study duration on the basis of suspicion of the clinical symptoms as fever, cough and weight loss. These patients were divided into three groups on the basis of the presentation of symptoms following the HSCT: that is <30 days, <100 days and >100 days of the post HSCT period and the pattern of the abnormalities were studied [711].

Thorough clinical examination was done to screen for pre-transplant chemotherapy. The follow-up for any post-transplant complications was done using a 16 slice Philips CT scan. The recommended position for this study was prone; however, supine position was kept reserved to critically ill patients. One mm thick slices of helical scans were acquired from the thoracic inlet to the diaphragm with a pitch of 1.0 and image reconstruction at 0.5mm intervals with high frequency reconstruction algorithm for lung and soft tissue algorithm [12].

The radiological findings were reported by two junior radiologists of 4 years of experience and reviewed by a senior radiologist of 26 years of experience. The senior radiologist was kept unaware of the clinical background of the patients. The results were correlated with the clinical, laboratory and radiological outcomes.

Study protocol HRCT acquisition was taken from the thoracic inlet till the diaphragm. The study is done as per values and parameter [Table/Fig-1] for Philips Brilliance 16 slice CT scanner [13].

The study protocol parameters.

ParameterValues
Length300mm
DirectionOut
Increment and thickness0.5mm and 1mm
*kV, mAs/Slice120,200
ResolutionHigh
Collimation16 x 0.75
Pitch0.938
Rotation time0.5 sec
§FOV300mm
WindowC-400, W 1200
Centre and MatrixX 0, Y 0 and 768

* kV-kilovolts, mAs/Slice- milli amperes seconds, §FOV-Field Of View


Statistical Analysis

With the help of Chi-square method different parameters studied were age group, patients chief complaints, sputum analysis and BAL correlation, ultrasound and routine investigation findings, personal history and biochemical parameters with the radiological findings.

Results

Out of the 52 patients, 35 were male and 17 were female with age varies from 1 to 72 years. There were total 9 children and 43 adults. The number of deaths noticed in the study was 2 among children and 3 among the adults (2 females and 3 males).

A total of 16 cases had normal HRCT chest, followed by non-specific findings as fibrosis, consolidation with sterile bronchial fluid, bronchiectatic changes, chronic GvHD, tuberculosis, bacterial pneumonia and viral pneumonia. Twelve cases had consolidation with sterile bronchial fluid, fibrosis, bronchiectatic changes, chronic GvHD, tuberculosis, bacterial pneumonia and viral pneumonia. Most of these findings were not observed on the conventional radiograph.

The common findings in the neutropenic patients were bilateral consolidations, mass like lesion and ground glass opacities in one patients turned fungal pneumonia later, ill defined opacities, ground glass opacities at bilateral lower lobes turned to be CMV positive pneumonia later, bilateral patchy consolidation and ground glass opacities later diagnosed as idiopathic pneumonia syndrome and patchy consolidation and ground glass opacities in one case later detected positive for Gram-negative bacilli. These cases were excluded later due to non-engraftment.

Cough was the most common presenting symptom in this study followed by fever and weight loss [Table/Fig-2]. Most of the patients had positive radiological findings after 100 days of HSCT however this is not statistically significant (p-values of all are >0.05).

Chief complaints and distribution of post-transplant HRCT (Radiological Findings).

SymptomsPost transplant HRCT (Radiological Findings)TotalChi-square valuep-value
PT1PT2PT3PT4PT5PT6
Fever (number of patients)Yes381044208.950.111
No344412532
Total6125416952
Weight (number of patients) lossYes272222177.670.176
No453214735
Total6125416952
Cough (number of patients)Yes51044155436.860.231
No1210149
Total6125416952
Duration of Radiological features from transplant (days)31-10021110166.060.3
>1004114316846
Total6125416952

PT 1- stands for fibrotic changes

PT 2- stands for consolidation.

PT 3- stands for cavities

PT 4- stands for bronchiectatic changes and tree in bud appearence

PT 5- stands for normal.

PT 6- stands for ground glass opacities and ill defined opacities.


Most of the pulmonary complications were found at >100 days followed by <100 and <30 days respectively [Table/Fig-3]. The patients presenting with early symptoms (<30 days) were associated with prolonged neutropenia and later excluded due to non-engraftment. The patients who died in the study (in 5 patients) had consolidation as the most common lung finding (in 4 patients). Most common cause of death among the patients in the study was due to sepsis (in 3 patients) followed by low counts of all cell lines except one patient who died due to gastrointestinal tract symptoms with Venous Occlusive Disease (VOD).

Duration of radiological findings with transplant (days).

The [Table/Fig-4] demonstrates that the sputum or bronchial fluid was frequently sterile (in 32 patients) followed by fungal (in 10 patients), tubercular (in 5 patients), bacterial (in 3 patients) and of viral origin (in 2 patients). The correlation for this finding was statistically significant (p-value=0.029). In the final diagnosis the most common findings were of group1 of bronchial fluid analysis associated with group 5 of radiological findings. The final diagnosis was statistically significant with these findings (p-value 0.002).

The statistical significance between the bronchial fluid analysis and the radiological findings. The sputum fluid/ Bronchial fluid analysis are coded in five groups (GR1-5).

Post transplant HRCT (Radiological Findings)TotalChi-square valuep-value
PT1PT2PT3PT4PT5PT6
Sputum/bronchial fluid analysisGR147441594327.010.029
GR22010003
GR30300104
GR40200002
Total6125416952
Final diagnosisGR121331583242.80.002
GR22120005
GR30200103
GR40200002
GR526010110
Total6125416952

GR1-Group 1 for sterile and non specific.

GR2-Group 2 for tuberculosis.

GR3-Group 3 for bacterial origin.

GR4-Group 4 for viral markers positive.

GR5-Group 5 for fungal origin.


The [Table/Fig-5] describes the statistical analysis of personal history with the health status of the patients. There was no statistically significant correlation of healthy and dead patients with the history of smoking (p-value=0.282), alcohol consumption (p-value=0.282) or diet (p-value=0.158). The [Table/Fig-6] describes the statistical analysis between the biochemical examinations and the follow-up health status of the patients under study. There were deaths of 2 out of 5 patients with abnormal Liver Function Test (LFT) while 3 out of 47, among patients with normal LFT. The result was statistically significant (p-value= 0.015). In the study the normal ranges considered were:

Personal history with follow-up health status till date.

Follow-up status till dateTotalChi-square valuep-value
HealthyDeath
SmokingYes9091.160.282
No38543
Total47552
AlcoholYes9091.160.282
No38543
Total47552
DietMixed and patients on total parental nutrition251261.990.158
Vegetarian22426
Total47552

Biochemical analysis with health follow-up status till date.

Follow-up status till dateTotalChi-square valuep-value
HealthyDeath
Liver function testNormal443475.880.015
Abnormal325
Total47552
Renal function testNormal474519.580.002
Abnormal011
Total47552
ElectrolytesNormal4735019.55<0.001
Abnormal022
Total47552

ALT - 7 to 55 units per litre (U/L)

AST - 8 to 48 (U/L)

ALP - 45 to 115 (U/L)

Albumin - 3.5 to 5.0 (g/dL)

Total protein - 6.3 to 7.9 (g/dL)

Bilirubin - 0.1 to 1.0 (mg/dL)

GGT - 9 to 48 (U/L)

LD - 122 to 222 (U/L)

In relation to Renal Function Test (RFT), there was death of only 1 patient with abnormal RFT while 4 out of 51 among patients with normal RFT (p-value= 0.002).

In this study there was death of all the 2 patients with abnormal serum electrolytes while 3 out of 50 patients with normal serum electrolytes (p-value< 0.001).

The [Table/Fig-7] describe the role of routine imaging work up in the HSCT patients. The 5 patients who died during the study, had normal chest radiograph but there were positive findings on HRCT chest (p-value=0.001). The patients had abnormal abdominal ultrasound (USG) scan however these abnormalities were incidental.

Results of the ultrasound abdomen and X ray chest and the follow-up findings.

Follow-up status till dateTotalChi-square valuep-value
HealthyDeath
Chest x ray FindingsNormal47552Not calculatedNot calculated
Total47552
USG findingsNormal363390.6640.415
Abnormal11213
Total47552

The [Table/Fig-8] describes the group statistics with t-test for the healthy and dead patients with their vital parameters i.e., temperature (T-F), pulse (p/minute) and respiratory rate (R/R/minute). The patients who died later had a mean body temperature 99.940F with a standard deviation of 1.29 however this was not statistically significant (p-value=0.098). The patients who died later had a mean pulse of 94.80 before death with standard deviation of 12.93 which was statistically significant (p-value =0.029). Similarly, the respiratory rate of the patient who died later had a mean of 19.00 with a standard deviation of 3.67 however, this was not statistically significant (p-values=0.132).

Vitals and its relation with Health Status of patients.

Group Statistics
Follow-up status till dateNMeanStd. Deviationp-value
Temperature (F)Healthy4799.190.910.098
Death599.941.29
Pulse rate (per minute)Healthy4781.1912.840.029
Death594.8012.93
Respiratory rate (per minute)Healthy4716.852.920.132
Death519.003.67

t-test


Discussion

The results of the study demonstrate that the HRCT chest is an important and very useful investigation in the case of HSCT transplant patients as it provides an early diagnosis and thus early treatment.

The present study states that most of the cases had normal HRCT chest, followed by non-specific finding as consolidation with sterile bronchial fluid, fibrosis, bronchiectatic changes, chronic GvHD, tuberculosis [Table/Fig-9a-c], bacterial pneumonia and viral pneumonia. Most of these findings were not observed on the conventional radiograph.

A 46-year-old female a known case of AML with chief complaints of cough. Radiographic findings 8 months after the transplant. This patient was found positive for acid fast bacilli. (a) Chest radiograph of this patient appearing normal. (b) Axial view of a patient of AML with tuberculosis showing small cavity with surrounding ground glass opacities in right lower lobe. (c) Axial view in mediastinal window showing calcified lymph node.

The analysis of the bronchial fluid and sputum examination was very helpful in establishing the diagnosis and were equally contributory for the radio-pathological correlation of the study. Most common findings among them were non-specific [Table/Fig-10a-c] and sterile fluid analysis followed by fungal, tubercular, bacterial and viral aetiology. These results helped to start the appropriate chemotherapeutic agent to control the complications and contributed in the early management of the complications.

A 19-year-old female known case of Fanconi’s anaemia presented with fever and weight loss after 8 months of transplant. Patient died later due to chronic graft rejection with abdominal complications. (a) Chest radiograph of the patients appears normal. (b) HRCT chest coronal view showing ground glass opacities are noted in both lungs with patchy consolidation in right upper lobe. (c) Coronal view of the patient showing few nodular lesions are noted in right upper lobe along with ground glass opacities in right middle lobe. Some scattered bronchiectatic lesions are noticed in left upper lobe and right lower lobe.

As per this study, the most common presenting symptoms was cough followed by fever and weight loss (wt loss). Most of these patients were observed with positive radiological findings after 100 days of HSCT [Table/Fig-11a,b]. Pulmonary complications are the most life threatening conditions that develop in HSCT recipients [14].

(a) Axial view showing air bronchograms at right lower lobe and collapse consolidation of the left lower lobe, the fixation screws are visible for the pathological fracture of the dorsal vertebra. (b) Bone window axial view of the patient showing multiple lytic areas in the sternum and ribs with fixation of the pathological fractures in dorsal vertebrae.

Similar findings have been described in other studies [1520]. These findings were diagnosed and treated early in the study led to the survival rate of greater than 90 percent.

This study also proved that, the pulmonary complications of HSCT were unrelated statistically with the hobbies, personal habits like alcohol consumption or smoking and dietary habits.

The mortality appeared high in the patients with deranged liver and renal function tests; however, this was not proved in all patients who died during the study.

A study of Hatzimichael states that, the major causes of mortality were late recurrence of original malignant disease, chronic GvHD, late infections without GvHD, secondary malignancies, pulmonary and cardiac complications [5]. Up to 1/5th of long-term survivors have functional impairments for many years after HSCT. Late complications of the HSCT include treatment regimen toxicities, immune deficiency, autoimmune syndromes, and growth impairment in children, cognitive dysfunction, second malignancies, chronic GvHD and abnormalities with psycho-social adjustment. These late effects can deteriorate performance for the day to day activities, sense of personal well-being, and inter-personal and family relationships. As compared with above study, our study found that the mortality was only 5 among total 52 patients taken in the study. This is about 9.6% in the studied sample with survival of 91.4% of the patients still kept good health after HSCT. Similarly as the death of one patient was noticed after 3 years, it shows that, the risk of delayed mortality is even higher in the recipients.

Another study of Coelho LOM et al., described that, there were about 60% patients who had consolidation, 50% centri-lobular nodules, 40% ground glass opacities [Table/Fig-12a-c], 20% large nodules, 10% pleural opacities and 10% had the tree in bud opacities [21]. As per their study the presence of large nodules and visualization of the halo sign was most suggestive of fungal infection. Other high-resolution CT patterns were not helpful in distinguishing among the various types of infection seen in bone marrow transplant recipients. Similar results have been published in few more studies [2225]. As compared, our study states that, the positive findings were about 23% consolidation, 17% ground glass opacities, 11% fibrotic changes, 10% cavities and 8% had bronchiectatic changes. Over 1/3rd of the cases had normal HRCT chest. This study is stronger as we correlated the pathologies with the HRCT findings by pathological fluid analysis.

A 25-year-old male known case of Aplastic anaemia with chief complaints of fever and cough following 3 years of transplant. Patient was found positive for CMV infection in bronchial aspirate. (a) Radiograph chest appearing normal. (b) Axial section of the lung showing extensive ground glass opacities in bilateral lungs and few areas of patchy consolidation in right middle lobe, right lower lobe and left upper lobe. (c) Axial section of lungs with bilateral ground glass opacities and patchy consolidation in right lower lobe.

However, the differences among the studies with the present one could be explained on the basis of difference in the number of total patients, geographical population, environmental factors, socioeconomic status, statistical study group, objectives and manufacturer of CT.

Limitation

Few patients were excluded from the study due to non-engraftment but we had a significant scope for studying such patients for preventing future mortality of post-HSCT procedure. The patients selected were not uniformly divided based on the age groups, gender and diseases. Different geographical origin of the patients, inability in positioning the patients in pronation for HRCT was few of the other limitation. The radiation hazards associated could not be avoided.

Conclusion

The patients with HSCT always have a risk for various pulmonary complications; however the early use of HRCT chest helps in early diagnosis and treatment. The HRCT chest has been found normal on several occasions with positive history of pulmonary symptoms and in such cases the bronchial fluid analysis was complimentary for the management. Similarly, on various immunogenic conditions as GvHD and VOD the pathological fluid analysis was found normal with positive HRCT chest study, hence, the use of both the modalities was the most favourable approach in such cases. Similarly mortality was higher in patients with deranged counts or abnormal organ function tests, hence these should be considered in the management and follow-up of such cases.

* kV-kilovolts, mAs/Slice- milli amperes seconds, §FOV-Field Of ViewPT 1- stands for fibrotic changesPT 2- stands for consolidation.PT 3- stands for cavitiesPT 4- stands for bronchiectatic changes and tree in bud appearencePT 5- stands for normal.PT 6- stands for ground glass opacities and ill defined opacities.GR1-Group 1 for sterile and non specific.GR2-Group 2 for tuberculosis.GR3-Group 3 for bacterial origin.GR4-Group 4 for viral markers positive.GR5-Group 5 for fungal origin.t-test

References

[1]Burt RK. H. Joachim Deeg. Bone Marrow Transplantation, WH 300 B712 1998. Pp. 478-518  [Google Scholar]

[2]Parikh PM, Shah PM, Easow Jose Kumar Lalit. 50 years of HSCT in India, MOHFW bulletin 2016. Pp.136-149. Available from: http://www.mohfw.nic.in/WriteReadData/l892s/Hematopoietic%20Stem%20Cell%20Transplantation%20In%20India.pdf  [Google Scholar]

[3]Korbling M, Przepiorka D, Huh YO, Allogeneic blood stem cell transplantation for refractory leukaemia and lymphoma: potential advantage of blood over marrow allografts Blood 1995 85:1659-65.  [Google Scholar]

[4]Santos GW, History of Bone Marrow Transplantation Clin Haem 1983 12:611-39.  [Google Scholar]

[5]Hatzimichael E, Tuthil M, Hematopoietic stem cell transplantation Stem Cells Cloning 2010 3:105-17.  [Google Scholar]

[6]Gyurkocza B, Sandmaier BM, Conditioning regimens for hematopoietic cell transplantation: one size does not fit all Blood 2014 124(3):344-53.  [Google Scholar]

[7]Soubani AO, Miller KB, Hassoun PM, Pulmonary complications of bone marrow transplantation Chest 1996 109:1066-77.  [Google Scholar]

[8]Gulbahce HE, Manivel JC, Jessurun J, Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation Am J Surg Pathol 2000 24:1147-52.  [Google Scholar]

[9]Kotloff RM, Ahya VN, Crawford SW, Pulmonary complications of solid and hematopoietic stem cell transplantation Am J Respir Crit Care Med 2004 170:22-48.  [Google Scholar]

[10]Freudenher TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC, Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants Blood 2003 102:3822-28.  [Google Scholar]

[11]Worthy SA, Flint JD, Müller NL, Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings Radio Graphics 1997 17:1359-71.  [Google Scholar]

[12]Padley SP, Adler B, Müller NL, High-resolution computed tomography of the chest: current indications J Thorac Imaging 1993 8(3):189-99.  [Google Scholar]

[13]Winklehner A, Berger N, Maurer B, Distler O, Alkadhi H, Frauenfelder T, Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices Ann Rheum Dis 2012 71(4):549-52.  [Google Scholar]

[14]Afessa B, Peters SG, Major complications following hematopoietic stem cell transplantation Semin Respir Crit Care Med 2006 27:297-309.  [Google Scholar]

[15]Marr KA, Anti-fungal prophylaxis in hematopoietic stem cell transplant recipients Curr Opin Infect Dis 2001 14:423-26.  [Google Scholar]

[16]Meyers JD, Infection in bone marrow transplant recipients Am J Med 1986 81:27-38.  [Google Scholar]

[17]Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity Blood 2003 101:407-14.  [Google Scholar]

[18]Andrei G, De CE, Snoeck R, Novel inhibitors of human CMV Curr Opin Investig Drugs 2008 9:132-45.  [Google Scholar]

[19]Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR, Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis Blood 1994 83:1971-79.  [Google Scholar]

[20]Schmidt-Hieber M, Schwarck S, Stroux A, Thiel E, Ganepola S, Uharek L, Prophylactic iv Igs in patients with a high risk for CMV after allo-SCT Bone Marrow Transplant 2009 44:185-92.  [Google Scholar]

[21]Coelho LOM, Gasparetto TD, Escuissato DL, Marchiori E, Bacterial pneumonia following bone marrow transplantation: HRCT findings J Bras Pneumol 2009 35(5):431-35.  [Google Scholar]

[22]Escuissato DL, Gasparetto EL, Marchiori E, Rocha Gde M, Inoue C, Pasquini R, Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients AJR Am J Roentgenol 2005 185(3):608-15.  [Google Scholar]

[23]Gosselin MV, Adams RH, Pulmonary complications in bone marrow transplantation J Thorac Imaging 2002 17(2):132-44.  [Google Scholar]

[24]Leung AN, Gosselin MV, Napper CH, Braun SG, Hu WW, Wong RM, Pulmonary infections after bone marrow transplantation: clinical and radiographic findings Radiology 1999 210(3):699-710.  [Google Scholar]

[25]Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E, Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study Transplantation 1995 60(7):672-78.  [Google Scholar]